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Background
In classic hereditary angioedema, inadequate C1-inhibitor
(C1-INH) failing to restrict factor-XII activity leads to
increased production of bradykinin, a potent vasodilator
and mediator of angioedema. Hereditary angioedema
with normal C1-INH (Type-III) manifests with sporadic
recurrent angioedema but normal C1-INH concentration
and activity. Here, bradykinin accumulation appears
dependent on Factor XII and Factor XII gene mutations
are sometimes found. Type-III angioedema affects almost
exclusively females, worse in pregnancy, on oral contra-
ceptives as estrogen may increase total bradykinin. Diag-
nosis is difficult given the clinical heterogeneity and lack
of biochemical indicators. Treatment carries various risks
when given for prophylaxis and a challenge for timely
administration in an acute crisis. This is the first case
report in the literature of a woman whose repeated
angioedema episodes resolved with surgical resection of
an ovarian cyst.
Case presentation
A 41-year-old woman presented with recurrent severe
episodes of face, tongue, and throat swelling occurring
under variable circumstances and without clear triggers.
C4 and C1-INH level and function were normal. Many
years after symptom onset, a large ovarian cyst was
diagnosed. Measured estrogen level was high. Once the
cyst was surgically removed, no further angioedema
occurred. Recently a son developed vibratory angioe-
dema, a rare form of physical urticaria. A first cousin
and niece in Italy have angioedema. Genome exome
sequencing is underway to determine if specific genetic
variations are contributing to this family cluster of
angioedema.
Conclusion
Resolution of Type-III hereditary angioedema manifesta-
tions by surgery upon diagnosing ovarian cysts as the
source of estrogen excess adds a new facet to the evalua-
tion and therapy for this condition. This family cluster of
angioedema proposes an interesting question of genetic
variations predisposing to angioedema.
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